Skip to main content

What is the difference between Lumify and Alphagan P?

Medically reviewed by Drugs.com. Last updated on Feb 16, 2024.

Official answer

by Drugs.com

Lumify is an over-the-counter (OTC) eye drop that contains low-dose brimonidine tartrate, whereas Alphagan P is a prescription eye care product that contains brimonidine at a higher strength.

Lumify (brimonidine tartrate ophthalmic solution 0.025%) is used for the treatment of ocular redness (red eyes), whereas Alphagan P (brimonidine tartrate, 0.1% or 0.15%) was first approved by the FDA for intraocular pressure (IOP) reduction in glaucoma patients.

Lumify, an alpha-adrenergic agonist eye drop, selectively constricts veins in the eye, increasing the availability of oxygen and reducing the potential risk of rebound redness (red eyes).

Read next

How does Xiidra differ from OTC dry eye treatments?

Xiidra (generic name: lifitegrast) eye drops contains lifitegrast, a prescription medication that is classified as a lymphocyte function-associated antigen-1 (LFA-1) antagonist. Over-the-counter dry (OTC) eye products are referred to as "artificial tears" which are usually made of a combination of glycerin and propylene glycol used for the temporary relief of irritation due to dryness of the eye. Continue reading

Xiidra vs. Restasis: Which is better for dry eye?

Xiidra (lifitegrast) and Restasis (cyclosporine) are prescription eye drops used to treat dry eye disease, but they work differently and have distinct characteristics. Continue reading

Are there any Restasis withdrawal symptoms?

Restasis withdrawal symptoms do not usually occur, but clinical studies have shown your persistent dry eye symptoms may return if you stop treatment. Depending upon your symptoms, you may need 3 to 6 months of Restasis treatment before your dry eyes start to improve. Restasis is typical meant for long-term use, but some patients may be able to stop treatment after 6 months. Continue reading

Related medical questions

Drug information

Related support groups